Current perspectives on diagnosis of heart failure in long-term dialysis patients

American Journal of Kidney Diseases

Volumn 57, Issue 2, 2011, Pages 308-319

  Wang, Angela Yee Moon ^a   Sanderson, John E ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

diagnosis; dialysis; diastolic dysfunction; Heart failure; systolic

Indexed keywords

AGE; ANEMIA; DIAGNOSTIC ACCURACY; DIALYSIS; DIASTOLIC DYSFUNCTION; DISEASE COURSE; DISEASE SEVERITY; HEART FAILURE; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HEART VOLUME; HUMAN; HYPERTENSION; HYPOALBUMINEMIA; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LONG TERM CARE; LUNG CONGESTION; PERIPHERAL EDEMA; PREVALENCE; REVIEW; SURVIVAL; SYSTOLIC DYSFUNCTION; UREMIA;

HEART FAILURE; HUMANS; KIDNEY FAILURE, CHRONIC; PREVALENCE; RENAL DIALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 78751624559     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.07.019     Document Type: Review

References (111)

1. J.D. Harnett, R.N. Foley, G.M. Kent, P.E. Barre, D. Murray, and P.S. Parfrey Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors Kidney Int 47 3 1995 884 890
2. A.K. Cheung, M.J. Sarnak, and G. Yan Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study Kidney Int 65 6 2004 2380 2389
3. A.G. Stack, and W.E. Bloembergen A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients Am J Kidney Dis 38 5 2001 992 1000
4. A.Y. Wang, J. Woo, and C.W. Lam Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients? J Am Soc Nephrol 14 7 2003 1871 1879
5. J.M. Soucie, and W.M. McClellan Early death in dialysis patients: risk factors and impact on incidence and mortality rates J Am Soc Nephrol 7 10 1996 2169 2175
6. F.C. Trespalacios, A.J. Taylor, L.Y. Agodoa, G.L. Bakris, and K.C. Abbott Heart failure as a cause for hospitalization in chronic dialysis patients Am J Kidney Dis 41 6 2003 1267 1277
7. P.S. Parfrey, S.M. Griffiths, and J.D. Harnett Outcome of congestive heart failure, dilated cardiomyopathy, hypertrophic hyperkinetic disease, and ischemic heart disease in dialysis patients Am J Nephrol 10 3 1990 213 221
8. D. Banerjee, J.Z. Ma, A.J. Collins, and C.A. Herzog Long-term survival of incident hemodialysis patients who are hospitalized for congestive heart failure, pulmonary edema, or fluid overload Clin J Am Soc Nephrol 2 6 2007 1186 1190
9. R.N. Foley, C.A. Herzog, and A.J. Collins Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 study Kidney Int 63 4 2003 1462 1467
10. R.N. Foley, P.S. Parfrey, and J.D. Harnett Clinical and echocardiographic disease in patients starting end-stage renal disease therapy Kidney Int 47 1 1995 186 192
11. A.M. de Mattos, A. Siedlecki, and R.S. Gaston Systolic dysfunction portends increased mortality among those waiting for renal transplant J Am Soc Nephrol 19 6 2008 1191 1196
12. A.Y. Wang, M. Wang, and J. Woo Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients J Am Soc Nephrol 15 8 2004 2186 2194
13. S.C. Greaves, G.D. Gamble, J.F. Collins, G.A. Whalley, and D.N. Sharpe Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure Am J Kidney Dis 24 5 1994 768 776
14. F. Mallamaci, C. Zoccali, and G. Tripepi Diagnostic potential of cardiac natriuretic peptides in dialysis patients Kidney Int 59 4 2001 1559 1566
15. R.N. Foley, P.S. Parfrey, G.M. Kent, J.D. Harnett, D.C. Murray, and P.E. Barre Long-term evolution of cardiomyopathy in dialysis patients Kidney Int 54 5 1998 1720 1725
16. C. Zoccali, F.A. Benedetto, and F. Mallamaci Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression Kidney Int 65 4 2004 1492 1498
17. R.N. Foley, P.S. Parfrey, G.M. Kent, J.D. Harnett, D.C. Murray, and P.E. Barre Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease J Am Soc Nephrol 11 5 2000 912 916
18. A.Y. Wang, C.W. Lam, I.H. Chan, M. Wang, S.F. Lui, and J.E. Sanderson Sudden cardiac death in end-stage renal disease patients: a 5-year prospective analysis Hypertension 56 2 2010 210 216
19. W.J. Paulus, C. Tschope, and J.E. Sanderson How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology Eur Heart J 28 20 2007 2539 2550
20. S.R. Ommen, R.A. Nishimura, and C.P. Appleton Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler- catheterization study Circulation 102 15 2000 1788 1794
21. S.F. Nagueh, K.J. Middleton, H.A. Kopelen, W.A. Zoghbi, and M.A. Quinones Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures J Am Coll Cardiol 30 6 1997 1527 1533
22. S.F. Nagueh, N.M. Lakkis, K.J. Middleton, W.H. Spencer III, W.A. Zoghbi, and M.A. Quinones Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy Circulation 99 2 1999 254 261
23. S.F. Nagueh, I. Mikati, H.A. Kopelen, K.J. Middleton, M.A. Quinones, and W.A. Zoghbi Doppler estimation of left ventricular filling pressure in sinus tachycardia A new application of tissue doppler imaging Circulation 98 16 1998 1644 1650
24. W. Mullens, A.G. Borowski, R.J. Curtin, J.D. Thomas, and W.H. Tang Tissue Doppler imaging in the estimation of intracardiac filling pressure in decompensated patients with advanced systolic heart failure Circulation 119 1 2009 62 70
25. A.Y. Wang, M. Wang, C.W. Lam, I.H. Chan, Y. Zhang, and J.E. Sanderson Left ventricular filling pressure by Doppler echocardiography in patients with end-stage renal disease Hypertension 52 1 2008 107 114
26. R.N. Foley, P.S. Parfrey, J.D. Harnett, G.M. Kent, D.C. Murray, and P.E. Barre Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease Kidney Int 49 5 1996 1379 1385
27. E.H. Ie, T.L. De Backer, and S.G. Carlier Ultrafiltration improves aortic compliance in haemodialysis patients J Hum Hypertens 19 6 2005 439 444
28. J.D. Harnett, G.M. Kent, R.N. Foley, and P.S. Parfrey Cardiac function and hematocrit level Am J Kidney Dis 25 4 suppl 1 1995 S3 S7
29. R.N. Foley, P.S. Parfrey, J.D. Harnett, G.M. Kent, D.C. Murray, and P.E. Barre The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease Am J Kidney Dis 28 1 1996 53 61
30. G.M. London, S.J. Marchais, A.P. Guerin, and F. Metivier Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia Curr Opin Nephrol Hypertens 14 6 2005 525 531
31. A.P. Guerin, S.J. Marchais, F. Metivier, and G.M. London Arterial structural and functional alterations in uraemia Eur J Clin Invest 35 suppl 3 2005 85 88
32. A.Y. Wang, M. Wang, and J. Woo A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients Kidney Int 62 2 2002 639 647
33. A.Y. Wang, C.W. Lam, M. Wang, I.H. Chan, S.F. Lui, and J.E. Sanderson Is valvular calcification a part of the missing link between residual kidney function and cardiac hypertrophy in peritoneal dialysis patients? Clin J Am Soc Nephrol 4 10 2009 1629 1636
34. A.Y. Wang, C.W. Lam, and J.E. Sanderson Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study Am J Clin Nutr 87 6 2008 1631 1638
35. G.M. London, A.P. Guerin, and F.H. Verbeke Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency J Am Soc Nephrol 18 2 2007 613 620
36. A. Zittermann, S.S. Schleithoff, G. Tenderich, H.K. Berthold, R. Korfer, and P. Stehle Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 41 1 2003 105 112
37. G.M. London Left ventricular alterations and end-stage renal disease Nephrol Dial Transplant 17 suppl 1 2002 29 36
38. C.W. McIntyre Effects of hemodialysis on cardiac function Kidney Int 76 4 2009 371 375
39. B. Levine, J. Kalman, L. Mayer, H.M. Fillit, and M. Packer Elevated circulating levels of tumor necrosis factor in severe chronic heart failure N Engl J Med 323 4 1990 236 241
40. E. Braunwald Biomarkers in heart failure N Engl J Med 358 20 2008 2148 2159
41. J. Niebauer, H.D. Volk, and M. Kemp Endotoxin and immune activation in chronic heart failure: a prospective cohort study Lancet 353 9167 1999 1838 1842
42. C.A. Chidsey, D.C. Harrison, and E. Braunwald Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure N Engl J Med 267 1962 650 654
43. J.N. Cohn, T.B. Levine, and M.T. Olivari Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure N Engl J Med 311 13 1984 819 823
44. C. Zoccali, F. Mallamaci, and S. Parlongo Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease Circulation 105 11 2002 1354 1359
45. C. Zoccali, F. Mallamaci, and G. Tripepi Norepinephrine and concentric hypertrophy in patients with end-stage renal disease Hypertension 40 1 2002 41 46
46. K. Swedberg, P. Eneroth, J. Kjekshus, and L. Wilhelmsen Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality CONSENSUS Trial Study Group Circulation 82 5 1990 1730 1736
47. R. Latini, S. Masson, and I. Anand The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT Eur Heart J 25 4 2004 292 299
48. M. Jessup, W.T. Abraham, and D.E. Casey 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 14 2009 1977 2016
49. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients Am J Kidney Dis 45 4 suppl 3 2005 S1 S153
50. D. Bello, D.J. Shah, and G.M. Farah Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy Circulation 108 16 2003 1945 1953
51. R.S. Vasan, M.G. Larson, E.J. Benjamin, J.C. Evans, C.K. Reiss, and D. Levy Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort J Am Coll Cardiol 33 7 1999 1948 1955
52. T.J. Wang, J.C. Evans, E.J. Benjamin, D. Levy, E.C. LeRoy, and R.S. Vasan Natural history of asymptomatic left ventricular systolic dysfunction in the community Circulation 108 8 2003 977 982
53. G.W. Yip, M. Frenneaux, and J.E. Sanderson Heart failure with a normal ejection fraction: new developments Heart 95 19 2009 1549 1552
54. Y.T. Tan, F. Wenzelburger, and E. Lee The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion J Am Coll Cardiol 54 1 2009 36 46
55. S.F. Nagueh, C.P. Appleton, and T.C. Gillebert Recommendations for the evaluation of left ventricular diastolic function by echocardiography Eur J Echocardiogr 10 2 2009 165 193
56. A.M. Pritchett, D.W. Mahoney, S.J. Jacobsen, R.J. Rodeheffer, B.L. Karon, and M.M. Redfield Diastolic dysfunction and left atrial volume: a population-based study J Am Coll Cardiol 45 1 2005 87 92
57. P.S. Douglas The left atrium: a biomarker of chronic diastolic dysfunction and cardiovascular disease risk J Am Coll Cardiol 42 7 2003 1206 1207
58. A.A. Alsaileek, M. Osranek, K. Fatema, R.B. McCully, T.S. Tsang, and J.B. Seward Predictive value of normal left atrial volume in stress echocardiography J Am Coll Cardiol 47 5 2006 1024 1028
59. T.K. Lim, H. Ashrafian, G. Dwivedi, P.O. Collinson, and R. Senior Increased left atrial volume index is an independent predictor of raised serum natriuretic peptide in patients with suspected heart failure but normal left ventricular ejection fraction: implication for diagnosis of diastolic heart failure Eur J Heart Fail 8 1 2006 38 45
60. T.S. Tsang, W.P. Abhayaratna, and M.E. Barnes Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter? J Am Coll Cardiol 47 5 2006 1018 1023
61. R.M. Lang, M. Bierig, and R.B. Devereux Recommendations for chamber quantification Eur J Echocardiogr 7 2 2006 79 108
62. G. Tripepi, F.A. Benedetto, F. Mallamaci, R. Tripepi, L. Malatino, and C. Zoccali Left atrial volume in end-stage renal disease: a prospective cohort study J Hypertens 24 6 2006 1173 1180
63. G. Tripepi, F.A. Benedetto, F. Mallamaci, R. Tripepi, L. Malatino, and C. Zoccali Left atrial volume monitoring and cardiovascular risk in patients with end-stage renal disease: a prospective cohort study J Am Soc Nephrol 18 4 2007 1316 1322
64. M. Wang, G. Yip, and C.M. Yu Independent and incremental prognostic value of early mitral annulus velocity in patients with impaired left ventricular systolic function J Am Coll Cardiol 45 2 2005 272 277
65. G. Yip, M. Wang, Y. Zhang, J.W. Fung, P.Y. Ho, and J.E. Sanderson Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: time for a redefinition? Heart 87 2 2002 121 125
66. J.E. Sanderson Heart failure with a normal ejection fraction Heart 93 2 2007 155 158
67. S.F. Nagueh, C.P. Appleton, and T.C. Gillebert Recommendations for the evaluation of left ventricular diastolic function by echocardiography J Am Soc Echocardiogr 22 2 2009 107 133
68. K. Ates, G. Nergizoglu, and K. Keven Effect of fluid and sodium removal on mortality in peritoneal dialysis patients Kidney Int 60 2 2001 767 776
69. K. Kalantar-Zadeh, D.L. Regidor, and C.P. Kovesdy Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis Circulation 119 5 2009 671 679
70. H. Natori, S. Tamaki, and S. Kira Ultrasonographic evaluation of ventilatory effect on inferior vena caval configuration Am Rev Respir Dis 120 2 1979 421 427
71. F.L. Moreno, A.D. Hagan, J.R. Holmen, T.A. Pryor, R.D. Strickland, and C.H. Castle Evaluation of size and dynamics of the inferior vena cava as an index of right-sided cardiac function Am J Cardiol 53 4 1984 579 585
72. P. Wabel, U. Moissl, and P. Chamney Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload Nephrol Dial Transplant 23 9 2008 2965 2971
73. P. Machek, T. Jirka, U. Moissl, P. Chamney, and P. Wabel Guided optimization of fluid status in haemodialysis patients Nephrol Dial Transplant 25 2 2010 538 544
74. V. Wizemann, P. Wabel, and P. Chamney The mortality risk of overhydration in haemodialysis patients Nephrol Dial Transplant 24 5 2009 1574 1579
75. A. Santoro, E. Mancini, and C. Basile Blood volume controlled hemodialysis in hypotension-prone patients: a randomized, multicenter controlled trial Kidney Int 62 3 2002 1034 1045
76. A.D. Sinha, R.P. Light, and R. Agarwal Relative plasma volume monitoring during hemodialysis AIDS the assessment of dry weight Hypertension 55 2 2010 305 311
77. F. Mallamaci, F.A. Benedetto, and R. Tripepi Detection of pulmonary congestion by chest ultrasound in dialysis patients JACC Cardiovasc Imaging 3 6 2010 586 594
78. H. Yasue, M. Yoshimura, and H. Sumida Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure Circulation 90 1 1994 195 203
79. K. Hosoda, K. Nakao, and M. Mukoyama Expression of brain natriuretic peptide gene in human heart Production in the ventricle Hypertension 17 6 pt 2 1991 1152 1155
80. Q. Dao, P. Krishnaswamy, and R. Kazanegra Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting J Am Coll Cardiol 37 2 2001 379 385
81. M.R. Cowie, A.D. Struthers, and D.A. Wood Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care Lancet 350 9088 1997 1349 1353
82. M. Davis, E. Espiner, and G. Richards Plasma brain natriuretic peptide in assessment of acute dyspnoea Lancet 343 8895 1994 440 444
83. F.D. Hobbs, R.C. Davis, A.K. Roalfe, R. Hare, M.K. Davies, and J.E. Kenkre Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations BMJ 324 7352 2002 1498 1503
84. S. Anwaruddin, D.M. Lloyd-Jones, and A. Baggish Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study J Am Coll Cardiol 47 1 2006 91 97
85. K. Yamamoto, J.C. Burnett Jr, and M. Jougasaki Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy Hypertension 28 6 1996 988 994
86. A.S. Maisel, P. Krishnaswamy, and R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 3 2002 161 167
87. P.J. Hunt, A.M. Richards, M.G. Nicholls, T.G. Yandle, R.N. Doughty, and E.A. Espiner Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment Clin Endocrinol (Oxf) 47 3 1997 287 296
88. P.A. McCullough, R.M. Nowak, and J. McCord B-Type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study Circulation 106 4 2002 416 422
89. F.S. Apple, M.M. Murakami, L.A. Pearce, and C.A. Herzog Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death Clin Chem 50 12 2004 2279 2285
90. A.Y. Wang, C.W. Lam, and C.M. Yu N-Terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients J Am Soc Nephrol 18 1 2007 321 330
91. G. Tripepi, F. Mattace-Raso, and F. Mallamaci Biomarkers of left atrial volume: a longitudinal study in patients with end stage renal disease Hypertension 54 4 2009 818 824
92. M. Codognotto, A. Piccoli, and M. Zaninotto Renal dysfunction is a confounder for plasma natriuretic peptides in detecting heart dysfunction in uremic and idiopathic dilated cardiomyopathies Clin Chem 53 12 2007 2097 2104
93. Y. Takami, T. Horio, and Y. Iwashima Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF Am J Kidney Dis 44 3 2004 420 428
94. S. Niizuma, Y. Iwanaga, and T. Yahata Impact of left ventricular end-diastolic wall stress on plasma B-type natriuretic peptide in heart failure with chronic kidney disease and end-stage renal disease Clin Chem 55 7 2009 1347 1353
95. A.Y. Wang, C.W. Lam, and M. Wang Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients Nephrol Dial Transplant 24 6 2009 1962 1969
96. K. Thygesen, J.S. Alpert, and H.D. White Universal definition of myocardial infarction J Am Coll Cardiol 50 22 2007 2173 2195
97. A.Y. Wang, and K.N. Lai Use of cardiac biomarkers in end-stage renal disease J Am Soc Nephrol 19 9 2008 1643 1652
98. R.J. Aviles, A.T. Askari, and B. Lindahl Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction N Engl J Med 346 26 2002 2047 2052
99. C. deFilippi, S. Wasserman, and S. Rosanio Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis JAMA 290 3 2003 353 359
100. D.S. Ooi, D. Zimmerman, J. Graham, and G.A. Wells Cardiac troponin T predicts long-term outcomes in hemodialysis patients Clin Chem 47 3 2001 412 417
101. F. Mallamaci, C. Zoccali, and S. Parlongo Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients Am J Kidney Dis 40 1 2002 68 75
102. A.Y. Wang, C.W. Lam, and M. Wang Prognostic value of cardiac troponin T is independent of inflammation, residual renal function, and cardiac hypertrophy and dysfunction in peritoneal dialysis patients Clin Chem 53 5 2007 882 889
103. N.A. Khan, B.R. Hemmelgarn, M. Tonelli, C.R. Thompson, and A. Levin Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis Circulation 112 20 2005 3088 3096
104. T.W. Wallace, S.M. Abdullah, and M.H. Drazner Prevalence and determinants of troponin T elevation in the general population Circulation 113 16 2006 1958 1965
105. D.S. Ooi, P.A. Isotalo, and J.P. Veinot Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology Clin Chem 46 3 2000 338 344
106. K. Amann, M. Breitbach, E. Ritz, and G. Mall Myocyte/capillary mismatch in the heart of uremic patients J Am Soc Nephrol 9 6 1998 1018 1022
107. C.R. deFilippi, E.M. Thorn, and M. Aggarwal Frequency and cause of cardiac troponin T elevation in chronic hemodialysis patients from study of cardiovascular magnetic resonance Am J Cardiol 100 5 2007 885 889
108. A.Y. Wang, C.W. Lam, and C.M. Yu Troponin T, left ventricular mass, and function are excellent predictors of cardiovascular congestion in peritoneal dialysis Kidney Int 70 3 2006 444 452
109. S. David, P. Kumpers, V. Seidler, F. Biertz, H. Haller, and D. Fliser Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis Nephrol Dial Transplant 23 4 2008 1370 1377
110. P.B. Mark, G.A. Stewart, and R.T. Gansevoort Diagnostic potential of circulating natriuretic peptides in chronic kidney disease Nephrol Dial Transplant 21 2 2006 402 410
111. C. Sommerer, J. Beimler, and V. Schwenger Cardiac biomarkers and survival in haemodialysis patients Eur J Clin Invest 37 5 2007 350 356